Cargando…
Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease
This cross-sectional study tested the hypothesis that decreased serum levels of tetranectin (TN), a regulator of the fibrinolysis and proteolytic system, is associated with the presence and severity of CAD. We conducted a systematic serological and immunohistochemical (IHC) analysis to respectively...
Autores principales: | Chen, Yanjia, Han, Hui, Yan, Xiaoxiang, Ding, Fenghua, Su, Xiuxiu, Wang, Haibo, Chen, Qiujing, Lu, Lin, Zhang, Ruiyan, Jin, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665081/ https://www.ncbi.nlm.nih.gov/pubmed/26621497 http://dx.doi.org/10.1038/srep17632 |
Ejemplares similares
-
Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer
por: Arellano-Garcia, Martha E., et al.
Publicado: (2010) -
A potential role for tetranectin in mineralization during osteogenesis
Publicado: (1994) -
Association of decreased serum sTREM-1 level with the severity of coronary artery disease: Inhibitory effect of sTREM-1 on TNF-α- and oxLDL-induced inflammatory reactions in endothelial cells
por: Dai, Daopeng, et al.
Publicado: (2016) -
Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis
por: McDonald, Kenneth, et al.
Publicado: (2020) -
The In Vitro Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1
por: Schadt, Simone, et al.
Publicado: (2019)